Is Interparfums a Better Buy Than Kimberly-Clark?
Even as Kimberly-Clark fell -15% during the past Day, its peer Interparfums may be a better choice. Consistently evaluating alternatives is core to sound investment approach. Interparfums (IPAR) stock offers superior revenue growth across key periods, better profitability, and relatively lower valuation vs Kimberly-Clark (KMB) stock, suggesting you may be better off investing in IPAR
- IPAR’s Last 12 Months revenue growth was 7.0%, vs. KMB’s -3.1%.
- In addition, its Last 3-Year Average revenue growth came in at 14.9%, ahead of KMB’s -2.1%.
- IPAR leads on profitability over both periods – LTM margin of 19.2% and 3-year average of 18.9%.
A single stock can be risky, but there is a huge value to a broader, diversified approach. If you seek an upside with less volatility than holding an individual stock, consider the Trefis High Quality Portfolio (HQ). HQ has outperformed its benchmark — a combination of S&P 500, Russell, and S&P midcap index — and achieved returns exceeding 91% since its inception. Risk management is key — consider what the long-term portfolio performance could be if you blended 10% commodities, 10% gold, and 2% crypto with HQ’s performance metrics.
KMB manufactures and markets personal care and tissue products, including wipers, towels, soaps, and consumer tissues under various well-known brands. IPAR manufactures, markets, and distributes fragrances and related products globally under various luxury and lifestyle brand names.
Valuation & Performance Overview
- Pay Less, Gain More: CLX Tops Kimberly-Clark Stock
- S&P 500 Stocks Trading At 52-Week Low
- S&P 500 Stocks Trading At 52-Week Low
- S&P 500 Stocks Trading At 52-Week Low
- Better Bet Than Kimberly-Clark Stock: Pay Less To Get More From CLX
- Better Bet Than Kimberly-Clark Stock: Pay Less To Get More From CLX
| KMB | IPAR | Preferred | |
|---|---|---|---|
| Valuation | |||
| P/EBIT Ratio | 10.7 | 10.4 | IPAR |
| Revenue Growth | |||
| Last Quarter | -1.6% | -2.4% | KMB |
| Last 12 Months | -3.1% | 7.0% | IPAR |
| Last 3 Year Average | -2.1% | 14.9% | IPAR |
| Operating Margins | |||
| Last 12 Months | 16.7% | 19.2% | IPAR |
| Last 3 Year Average | 15.2% | 18.9% | IPAR |
| Momentum | |||
| Last 3 Year Return | -6.5% | 22.5% | IPAR |
Note: For “Last 3 Year Return” metric, preferred stock is one with higher returns unless the returns are too high (>300%) which creates risk of sell off.
See more revenue details: KMB Revenue Comparison | IPAR Revenue Comparison
See more margin details: KMB Operating Income Comparison | IPAR Operating Income Comparison
But do these numbers tell the full story? Read Buy or Sell IPAR Stock to see if Interparfums’s edge holds up under the hood or if Kimberly-Clark still has cards to play (see Buy or Sell KMB Stock).
Historical Market Performance
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Total [1] | Avg | Best | |
|---|---|---|---|---|---|---|---|---|---|
| Returns | |||||||||
| KMB Return | 1% | 10% | -2% | -7% | 12% | -20% | 6% | ||
| IPAR Return | -16% | 79% | -7% | 52% | -6% | -30% | 37% | ||
| S&P 500 Return | 16% | 27% | -19% | 24% | 23% | 16% | 112% | <=== | |
| Monthly Win Rates [3] | |||||||||
| KMB Win Rate | 58% | 50% | 42% | 33% | 50% | 40% | 46% | ||
| IPAR Win Rate | 50% | 67% | 33% | 58% | 42% | 20% | 45% | ||
| S&P 500 Win Rate | 58% | 75% | 42% | 67% | 75% | 70% | 64% | <=== | |
| Max Drawdowns [4] | |||||||||
| KMB Max Drawdown | -18% | -5% | -21% | -11% | -3% | -8% | -11% | <=== | |
| IPAR Max Drawdown | -51% | -2% | -39% | 0% | -23% | -31% | -24% | ||
| S&P 500 Max Drawdown | -31% | -1% | -25% | -1% | -2% | -15% | -12% | ||
[1] Cumulative total returns since the beginning of 2020
[2] 2025 data is for the year up to 11/3/2025 (YTD)
[3] Win Rate = % of calendar months in which monthly returns were positive
[4] Max drawdown represents maximum peak-to-trough decline within a year
No matter how good the numbers, stock investment is never a smooth ride. There is a risk you must factor in. Read IPAR Dip Buyer Analyses to see how the stock has fallen and recovered in the past.
Whatever your view on either of these stocks, investing in one or two stocks remains a risky proposition. Instead, the Trefis High Quality (HQ) Portfolio, with a collection of 30 stocks, has a track record of comfortably outperforming its benchmark that includes all 3 — the S&P 500, S&P mid-cap, and Russell 2000 indices. Why is that? As a group, HQ Portfolio stocks provided better returns with less risk versus the benchmark index; less of a roller-coaster ride, as evident in HQ Portfolio performance metrics.